MTA1 and prostate carcinoma: We recently reported that Gnetin C acts through MTA1/ETS2-mediated mechanisms in prostate cancer and shows significant MTA1-mediated inhibitory effects on cell viability, colony formation, and migration while inducing cell cycle arrest and cell death [28].